These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2575423)

  • 1. Correlates of positive and negative schizophrenic syndromes in Nigerian patients.
    Gureje O
    Br J Psychiatry; 1989 Nov; 155():628-32. PubMed ID: 2575423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndromes of chronic schizophrenia and some clinical correlates.
    Brown KW; White T
    Br J Psychiatry; 1992 Sep; 161():317-22. PubMed ID: 1356571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of positive and negative syndromes in chronic schizophrenia.
    Kay SR; Opler LA; Fiszbein A
    Br J Psychiatry; 1986 Oct; 149():439-48. PubMed ID: 3814927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive and negative syndromes in chronic schizophrenic inpatients.
    Opler LA; Kay SR; Rosado V; Lindenmayer JP
    J Nerv Ment Dis; 1984 Jun; 172(6):317-25. PubMed ID: 6152720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Movement disorder in never and minimally treated Nigerian schizophrenic patients.
    McCreadie RG; Ohaeri JU
    Br J Psychiatry; 1994 Feb; 164(2):184-9. PubMed ID: 7909712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological abnormalities in schizophrenic patients.
    Torrey EF
    Biol Psychiatry; 1980 Jun; 15(3):381-8. PubMed ID: 7378515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients.
    Braff DL; Swerdlow NR; Geyer MA
    Am J Psychiatry; 1999 Apr; 156(4):596-602. PubMed ID: 10200740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The two-syndrome concept: origins and current status.
    Crow TJ
    Schizophr Bull; 1985; 11(3):471-86. PubMed ID: 2863873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy.
    Peralta V; de Leon J; Cuesta MJ
    Br J Psychiatry; 1992 Sep; 161():335-43. PubMed ID: 1356572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex uno multi: subtyping the schizophrenic syndrome.
    Jeste DV; Kleinman JE; Potkin SG; Luchins DJ; Weinberger DR
    Biol Psychiatry; 1982 Feb; 17(2):199-222. PubMed ID: 6122474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive asymmetry patterns in schizophrenia: active and withdrawn syndromes and sex differences as moderators.
    Gruzelier JH; Wilson L; Liddiard D; Peters E; Pusavat L
    Schizophr Bull; 1999; 25(2):349-62. PubMed ID: 10416736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateralized cerebral impairment in schizophrenia. A critical review.
    Cazzullo CL; Gambini O; Pieri E; Scarone S
    Acta Psychiatr Belg; 1984; 84(4):310-24. PubMed ID: 6391089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of soft neurological signs in positive and negative subtype of schizophrenia.
    Cvetić T; Vuković O; Britvić D; Ivković M; Dukić-Dejanović S; Lecić-Tosevski D
    Psychiatr Danub; 2009 Jun; 21(2):174-8. PubMed ID: 19556945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders.
    Peralta V; de Jalón EG; Campos MS; Basterra V; Sanchez-Torres A; Cuesta MJ
    Psychol Med; 2011 Jun; 41(6):1279-89. PubMed ID: 20860873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurological soft signs in early onset schizophrenia].
    Bourgou Gaha S; Halayem Dhouib S; Amado I; Bouden A
    Encephale; 2015 Jun; 41(3):209-14. PubMed ID: 24854724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The positive-negative dimension in schizophrenia: its validity and significance.
    Kay SR; Opler LA
    Psychiatr Dev; 1987; 5(2):79-103. PubMed ID: 2888108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological signs and the heterogeneity of schizophrenia.
    Arango C; Kirkpatrick B; Buchanan RW
    Am J Psychiatry; 2000 Apr; 157(4):560-5. PubMed ID: 10739414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive correlates of positive and negative syndromes in schizophrenia.
    Voruganti LN; Heslegrave RJ; Awad AG
    Can J Psychiatry; 1997 Dec; 42(10):1066-71. PubMed ID: 9469239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.